Drugs / PYY1-36
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT02493959 | May 2014 → Jul 2015 | — | Hvidovre University Hospital | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00259233 | Mar → May 2005 | obesity disorder | University of Copenhagen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PYY1-36 | “12 obese subjects will receive peripheral administration of placebo and 4 escalating doses of PYY1-36 and another 12 obese subjects will receive peripheral administration of...” NCT00259233 ↗ |
| Modality | Peptide | “Degradation of the Anorexic Hormone Peptide YY” NCT02493959 ↗ |
| Route | Intravenous | “IV infusion on 4 separate days of PYY or saline in Healthy, normal-weight men, age 18-50 years” NCT02493959 ↗ |